Cannabis sativa Linn.: A Medicinal Plant with Promising Muscle Relaxant-related Constituents
Authors:
Open Access
- 8 April 2026
- journal article
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 16 (6) , 6-18
Abstract
Medicinal plants have served as a source of medicine since human existence. Cannabis sativa , also known as cannabis, or hemp, is one of the most widely known medicinal plants used for the management of ailments, including muscular and/or joint pains, and their associated injuries. Cannabis contains valuable secondary metabolites, terpenes (α-pinene, β-caryophyllene, limonene, and myrcene), terpenoids (camphor, linalool, and terpineol), phenolics (stilbene, spiroindan, and cannflavin), and phytocannabinoids [cannabidiol (CBD), delta-9-tetrahydrocannabinol (Δ 9 -THC), cannabinol (CBN), cannabigerol (CBG), and their acidic forms]. These classes of compounds are known to contribute to the analgesic, anti-inflammatory, anti-arthritis, and other muscle relaxant-related properties of cannabis. Structurally, phytocannabinoids with an extended side chain at position C3 can activate cannabinoid receptors, promoting inhibition of signaling pathways MAPK and cAMP associated with pain and inflammation. This review discusses C. sativa phytocompounds with muscle relaxant-related properties (inflammation, pain, and arthritis) and their structure-activity relationship, with a view to identifying natural muscle relaxants as possible drug candidates.Keywords
This publication has 87 references indexed in Scilit:
- Cannabidiol (CBD) and potential in medicinal use in rheumatoid arthritis2023
- Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overviewPhytotherapy Research, 2021
- Extraction of naturally occurring cannabinoids: an updatePhytochemical Analysis, 2020
- A Comprehensive Review of the Treatment and Management of Myofascial Pain SyndromeCurrent Pain and Headache Reports, 2020
- The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosisInflammation Research, 2020
- Cannabinoids in the Management of Musculoskeletal or Rheumatic DiseasesCurrent Rheumatology Reports, 2016
- CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016JAMA, 2016
- Cannabis sativa and Hemp2016
- Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritisEuropean journal of pain, 2015
- Endocannabinoids and Their Pharmacological Actions2015